OSR Health reported revenue of 0.48M and net income of -3.47M for the quarter ended Mar 2026, down 36.4% year over year. This income statement covers 17 quarters of results from Dec 2021 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2021 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||
| Revenue (Quarter)Revenue (Qtr) | 0.91M | 0.88M | 0.82M | 0.92M | 0.76M | 1.14M | 0.63M | 0.38M | 0.48M | ||||||||
| Cost of Revenue (Quarter)Cost of Rev (Qtr) | 0.67M | 0.65M | 0.64M | 0.76M | 0.59M | 1.10M | 0.37M | 0.25M | 0.32M | ||||||||
| Gross Profit (Quarter)Gross Profit (Qtr) | 0.24M | 0.23M | 0.18M | 0.16M | 0.17M | 0.03M | 0.26M | 0.13M | 0.16M | ||||||||
| Operating items | |||||||||||||||||
| Amortization - Intangibles (Quarter)Amortization - Intangibles (Qtr) | 2.90M | 2.78M | 2.82M | 2.27M | 2.35M | 2.39M | |||||||||||
| Research & Development (Quarter)R&D (Qtr) | 0.05M | 0.05M | 0.05M | 0.09M | 0.05M | -0.00M | |||||||||||
| Selling, General & Administrative (Quarter)SG&A (Qtr) | 988.00 | 0.02M | 0.01M | 0.28M | 0.28M | 0.41M | 0.86M | 3.54M | 3.44M | 3.75M | 1.77M | 3.09M | 5.26M | 4.07M | 6.52M | 3.83M | |
| Operating Expenses (Quarter)Opex (Qtr) | 988.00 | 0.02M | 0.01M | 0.28M | 0.28M | 0.41M | 0.86M | 3.59M | 3.49M | 3.80M | 1.77M | 3.18M | 5.32M | 4.06M | 6.52M | 3.83M | |
| Operating Income (Quarter)Op. Inc (Qtr) | -3.30M | -3.21M | -3.57M | -1.61M | -2.92M | -5.23M | -3.80M | -6.39M | -3.67M | ||||||||
| EBIT (Quarter)EBIT (Qtr) | -988.00 | -0.02M | -0.01M | 0.14M | 0.53M | 0.21M | 0.42M | -3.30M | -3.21M | -3.57M | -1.61M | -2.92M | -5.23M | -3.80M | -6.39M | -3.67M | |
| Non-operating items | |||||||||||||||||
| Interest & Investment Income (Quarter)Int & Inv Inc (Qtr) | 0.42M | 0.81M | 0.62M | 0.93M | 0.01M | 0.00M | 0.00M | 0.01M | 0.00M | 0.02M | 0.02M | 0.02M | 0.02M | ||||
| Other Non Operating Income (Quarter)Other Non Op Inc. (Qtr) | 0.03M | 0.03M | 0.08M | 0.00M | 0.03M | 0.22M | 0.02M | 4.12M | 0.00M | ||||||||
| Net income details | |||||||||||||||||
| EBT (Quarter)EBT (Qtr) | -988.00 | -0.02M | -0.01M | 0.14M | 0.53M | 0.21M | 0.07M | -3.36M | -3.25M | -3.50M | -1.79M | -11.39M | -5.23M | -4.49M | -7.78M | -3.92M | |
| Tax Provisions (Quarter)Taxes (Qtr) | 0.03M | 0.23M | 0.13M | 0.15M | 4.00 | -0.97M | -0.14M | -0.45M | -1.29M | -0.53M | -0.45M | ||||||
| Profit After Tax (Quarter)PAT (Qtr) | -988.00 | -0.02M | -0.01M | 0.11M | 0.30M | 0.08M | 1.37M | -3.36M | -2.27M | -3.36M | -1.31M | -10.93M | -5.23M | -3.63M | 9.88M | -3.47M | |
| Income from Non-Controlling Interests (Quarter)Inc. Minority (Qtr) | -5.56M | -1.82M | -0.42M | -1.54M | |||||||||||||
| Income from Continuing Operations (Quarter)Income (Continuing) (Qtr) | -988.00 | -0.02M | -0.01M | 0.11M | 0.30M | 0.08M | -0.09M | -3.36M | -2.28M | -3.36M | -1.34M | -11.39M | -5.23M | -3.19M | -7.25M | -3.47M | |
| Consolidated Net Income (Quarter)Consol Net Inc. (Qtr) | -988.00 | -0.02M | -0.01M | 0.11M | 0.30M | 0.08M | -0.09M | -3.36M | -2.28M | -3.36M | -1.34M | -11.39M | -5.23M | -3.19M | -7.25M | -3.47M | |
| Income towards Parent Company (Quarter)Parent Net Inc (Qtr) | -988.00 | -0.02M | -0.01M | 0.11M | 0.30M | 0.08M | -0.09M | -3.36M | -2.28M | -3.36M | -1.34M | -11.39M | -5.23M | -3.19M | -7.25M | -3.47M | |
| Net Income towards Common Stockholders (Quarter)Net Income (Qtr) | -988.00 | -0.02M | -0.01M | 0.11M | 0.30M | 0.08M | -0.09M | -3.36M | -2.28M | -3.36M | -1.34M | -11.39M | 0.33M | -2.13M | -4.82M | -2.93M | |
| Additional items | |||||||||||||||||
| EPS (Basic) (Quarter)EPS (Basic) (Qtr) | 0.00 | -0.01 | -0.01 | 0.02 | 0.03 | 0.01 | -0.01 | -0.60 | -0.46 | -0.83 | -0.30 | -1.04 | 0.02 | -0.12 | -0.25 | -0.09 | |
| EPS (Diluted) (Quarter)EPS (Diluted) (Qtr) | 0.00 | -0.01 | -0.01 | 0.02 | 0.03 | 0.01 | -0.01 | -0.60 | -0.46 | -0.83 | -0.30 | -1.04 | 0.02 | -0.09 | -0.21 | -0.09 | |
| Shares Outstanding (Quarter)Shares Outstanding (Qtr) | 1.50M | 1.50M | 1.50M | 1.50M | 5.23M | 9.05M | 9.05M | 7.69M | 5.62M | 4.95M | 4.04M | 4.48M | 10.91M | 15.16M | 17.38M | 19.52M | 31.21M |
| Shares Outstanding (Diluted) (Quarter)Shares Outstanding (Dil.) (Qtr) | 1.50M | 1.50M | 1.50M | 5.23M | 9.05M | 9.05M | 7.72M | 5.62M | 4.95M | 4.04M | 4.48M | 10.91M | 16.09M | 23.12M | 22.56M | 34.27M | |
| Shares Outstanding (Entity) (Quarter)Shares Outstanding (Entity.) (Qtr) | 1.73M | 1.73M | 1.73M | 1.73M | 5.23M | 9.05M | 9.05M | 7.69M | 5.62M | 4.95M | 4.04M | 4.48M | 10.91M | 15.16M | 17.38M | 19.52M | 33.30M |
| EBITDA (Quarter)EBITDA (Qtr) | -988.00 | -0.02M | -0.01M | 0.14M | 0.53M | 0.21M | 0.42M | -3.30M | -3.21M | -3.57M | -1.61M | -2.92M | -5.23M | -3.80M | -6.39M | -3.67M | |
| Interest Expenses (Quarter)Int Expense (Qtr) | 0.36M | 0.01M | 0.00M | 0.01M | 0.05M | 8.49M | 0.21M | 0.69M | 0.41M | 0.24M | |||||||
| Tax Rate (Quarter)Tax Rate (Qtr) | 21.00% | 43.12% | 62.42% | 228.87% | 0.00% | 29.95% | 3.99% | 25.17% | 28.84% | 6.87% | 11.54% |